IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 104
Titolo Data di pubblicazione Autore(i) File
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells 1-gen-2001 We, Carson; R, Parihar; Mj, Lindemann; Personeni, N.; J, Dierksheide; Nj, Meropol; J, Baselga; Ma, Caligiuri
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma 1-gen-2003 Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V.; Cascinu, S.
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer 1-gen-2005 Personeni, N.; Hendlisz, A.; Gallez, A.; Gomez Galdon, M.; Larsimont, D.; Van Laethem, Ji.; Nagy, N.; Barette, M.; Paesmans, M.; Cardoso, F.; Bleiberg, H.
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes 1-gen-2006 A, Hendlisz; Personeni, N.; T, Delaunoit; S, Debroux; P., Flamen
Response prediction to EGFR-targeted therapies in colorectal cancer 1-gen-2006 Personeni, N.; S, Tejpar; E., Van Cutsem
Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter? 1-gen-2006 Personeni, N.
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity 1-gen-2006 Bozzetti, C.; Musolino, A.; Camisa, R.; Bisagn, G.; Flora, M.; Bassano, C.; Martella, E.; Lagrasta, C.; Nizzoli, R.; Personeni, N.; Leonardi, F.; Cocconi, G.; Ardizzoni, A.
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer 1-gen-2007 M, Colozza; E, Azambuja; Personeni, N.; F, Lebrun; Mj, Piccart; F., Cardoso
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing? 1-gen-2007 Personeni, N.
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study 1-gen-2008 Personeni, N.; Fieuws, S.; Piessevaux, H.; De Hertogh, G.; De Schutter, J.; Biesmans, B.; De Roock, W.; Capoen, A.; Debiec Rychter, M.; Van Laethem, J.; Peeters, M.; Humblet, Y.; Van Cutsem, E.; Tejpar, S.
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab 1-gen-2008 W, De Roock; H, Piessevaux; J, De Schutter; M, Janssens; G, De Hertogh; Personeni, N.; B, Biesmans; Laethem Jl, Van; M, Peeters; Y, Humblet; E, Van Cutsem; S., Tejpar
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 1-gen-2010 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy 1-gen-2010 Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P.
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Giordano, L; Santoro, A
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 1-gen-2011 Simonelli, M; Zucali, Pa; De Sanctis, R; Lorenzi, E; De Vincenzo, F; Rimassa, L; Tronconi, Mc; Personeni, N; Masci, G; Zuradelli, M; Perrino, M; Bertossi, M; Giordano, L; Santoro, A
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection 1-gen-2011 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 1-gen-2011 Personeni, N.; Torzilli, G.; Santoro, A.
Biomarkers in Hepatocellular Carcinoma-Letter 1-gen-2012 Personeni, N; Rimassa, L; Santoro, A
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 1-gen-2012 Personeni, N; Bozzarelli, S; Pressiani, T; Rimassa, L; Tronconi, Mc; Sclafani, F; Carnaghi, C; Pedicini, V; Giordano, L; Santoro, A
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study 1-gen-2012 Sartore-Bianchi, Andrea; Fieuws, Steffen; Veronese, Silvio; Moroni, Mauro; Personeni, Nicola; Frattini, Milo; Torri, Valter; Cappuzzo, Federico; Borght Sara, Vander; Martin, Vittoria; Skokan, Margaret; Santoro, A; Gambacorta, Marcello; Tejpar, Sabine; Varella-Garcia, Marileila; Siena, Salvatore
Mostrati risultati da 1 a 20 di 104
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile